Carlos A. Torres‐Cabala

Author

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

C Torres-Cabala, C. A. Torres-Cabala, C. A. Torres‐Cabala, C. Carlos Torres-Cabala, C. Torres-Cabala, C.A. Torres-cabala, C.A. Torres‐Cabala, CARLOS A. TORRES-CABALA, CARLOS TORRES-CABALA, Carlos A Torres-Cabala

373

Publications

10K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center National Cancer Institute Center for Cancer Research In-Q-Tel The University of Texas Health Science Center at Houston

About

Carlos A. Torres‐Cabala is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	54	4K
2	Cell Biology	8	8	445
3	Engineering	3	3	161
4	Health Sciences	2	2	188
5	Computer Science	1	1	86

Carlos A. Torres‐Cabala

115

Publications

8.7K

Citations

H-Index

Page 1

	Year	Citations
Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy Weiyi Peng, Jie Qing Chen, Chengwen Liu, Cancer Discovery	2015	1.5K
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability Jennifer S. Isaacs, Yun Jin Jung, David R. Mole, Cancer Cell UrologyRenal FunctionFumarate HydrataseGenitourinary CancerMedicine	2005	935
The Morphologic Spectrum of Kidney Tumors in Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC) Syndrome Maria J. Merino, Carlos A. Torres‐Cabala, Peter A. Pinto, The American Journal of Surgical Pathology Cancer PathologyRenal PathologyPathologyTumor BiologyCarcinoma	2007	407
Neoadjuvant relatlimab and nivolumab in resectable melanoma Rodabe N. Amaria, Michael A. Postow, Elizabeth M. Burton, Nature	2022	312
EVALUATION AND MANAGEMENT OF RENAL TUMORS IN THE BIRT-HOGG-DUBÉ SYNDROME Christian P. Pavlovich, Robert L. Grubb, Kathleen Hurley, The Journal of Urology	2005	305
Hereditary Leiomyomatosis and Renal Cell Cancer: A Syndrome Associated With an Aggressive Form of Inherited Renal Cancer Robert L. Grubb, Michael Franks, Jorge R. Toro, The Journal of Urology	2007	281
High Frequency of Somatic Frameshift BHD Gene Mutations in Birt-Hogg-Dubé–Associated Renal Tumors Cathy D. Vocke, Youfeng Yang, Christian P. Pavlovich, JNCI Journal of the National Cancer Institute UrologySomatic VariantGenitourinary CancerGenetic DisorderBhd Locus	2005	236
Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type Carlos A. Torres‐Cabala, Wei‐Lien Wang, Jonathan C. Trent, Modern Pathology Tumor BiologyKit ExpressionAcral-lentiginous/mucosal TypeKit MutationMelanoma	2009	208
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer Di Ai, Jun Yao, Fei Yang, Modern Pathology Breast OncologyMedicinePathologyCancer GenomicsSpecific Marker	2020	188
Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor James R. Vasselli, Joanna H. Shih, Shuba R. Iyengar, Proceedings of the National Academy of Sciences UrologyOncologyGene-expression ProfilingMetastatic Kidney CancerTumor Heterogeneity	2003	175

Page 1